Phuong N. Huynh

Array ( [id] => 82674 [patent_doc_number] => 07740853 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Fcepsilon-pe chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same' [patent_app_type] => utility [patent_app_number] => 10/096840 [patent_app_country] => US [patent_app_date] => 2002-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 13 [patent_no_of_words] => 6504 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/740/07740853.pdf [firstpage_image] =>[orig_patent_app_number] => 10096840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6773812 [patent_doc_number] => 20030017150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses' [patent_app_type] => new [patent_app_number] => 10/099007 [patent_app_country] => US [patent_app_date] => 2002-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 36712 [patent_no_of_claims] => 101 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017150.pdf [firstpage_image] =>[orig_patent_app_number] => 10099007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6111138 [patent_doc_number] => 20020173005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Methods and materials relating to novel CD39-like polypeptides' [patent_app_type] => new [patent_app_number] => 10/092063 [patent_app_country] => US [patent_app_date] => 2002-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27167 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173005.pdf [firstpage_image] =>[orig_patent_app_number] => 10092063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1052880 [patent_doc_number] => 06858207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-22 [patent_title] => 'Methods and materials relating to novel CD39-like polypeptides' [patent_app_type] => utility [patent_app_number] => 10/091085 [patent_app_country] => US [patent_app_date] => 2002-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19189 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858207.pdf [firstpage_image] =>[orig_patent_app_number] => 10091085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846851 [patent_doc_number] => 20030166018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Methods for identifying agents that modulate mast cell degranulation' [patent_app_type] => new [patent_app_number] => 10/087144 [patent_app_country] => US [patent_app_date] => 2002-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20714 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166018.pdf [firstpage_image] =>[orig_patent_app_number] => 10087144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711032 [patent_doc_number] => 20030170781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Secreted protein zacrp4' [patent_app_type] => new [patent_app_number] => 10/085167 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28046 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170781.pdf [firstpage_image] =>[orig_patent_app_number] => 10085167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829236 [patent_doc_number] => 20030180294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Methods of extending corneal graft survival' [patent_app_type] => new [patent_app_number] => 10/081126 [patent_app_country] => US [patent_app_date] => 2002-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13492 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180294.pdf [firstpage_image] =>[orig_patent_app_number] => 10081126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567569 [patent_doc_number] => 20020165157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Apo-2LI and Apo-3 polypeptides' [patent_app_type] => new [patent_app_number] => 10/081280 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24188 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165157.pdf [firstpage_image] =>[orig_patent_app_number] => 10081280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6559254 [patent_doc_number] => 20020164624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'VEGF-D expression in brain cancer' [patent_app_type] => new [patent_app_number] => 10/075823 [patent_app_country] => US [patent_app_date] => 2002-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14725 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164624.pdf [firstpage_image] =>[orig_patent_app_number] => 10075823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374592 [patent_doc_number] => 20020119096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Fluorination of proteins and peptides for F-18 positron emission tomography' [patent_app_type] => new [patent_app_number] => 10/071247 [patent_app_country] => US [patent_app_date] => 2002-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4319 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119096.pdf [firstpage_image] =>[orig_patent_app_number] => 10071247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 216802 [patent_doc_number] => 07611711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'VEGFR-3 inhibitor materials and methods' [patent_app_type] => utility [patent_app_number] => 10/046922 [patent_app_country] => US [patent_app_date] => 2002-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27193 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/611/07611711.pdf [firstpage_image] =>[orig_patent_app_number] => 10046922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292068 [patent_doc_number] => 07544357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays' [patent_app_type] => utility [patent_app_number] => 10/466023 [patent_app_country] => US [patent_app_date] => 2002-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 40 [patent_no_of_words] => 16520 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544357.pdf [firstpage_image] =>[orig_patent_app_number] => 10466023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6274857 [patent_doc_number] => 20020106397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Immunogen adherence inhibitor and method of making and using same' [patent_app_type] => new [patent_app_number] => 10/039977 [patent_app_country] => US [patent_app_date] => 2002-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9225 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106397.pdf [firstpage_image] =>[orig_patent_app_number] => 10039977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985084 [patent_doc_number] => 20020098181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Immunogen adherence inhibitor and method of making and using same' [patent_app_type] => new [patent_app_number] => 10/038260 [patent_app_country] => US [patent_app_date] => 2002-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9117 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098181.pdf [firstpage_image] =>[orig_patent_app_number] => 10038260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5906335 [patent_doc_number] => 20020142445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same' [patent_app_type] => new [patent_app_number] => 10/036444 [patent_app_country] => US [patent_app_date] => 2002-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16786 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142445.pdf [firstpage_image] =>[orig_patent_app_number] => 10036444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739740 [patent_doc_number] => 20030157109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Antibodies directed to PDGFD and uses thereof' [patent_app_type] => new [patent_app_number] => 10/041860 [patent_app_country] => US [patent_app_date] => 2002-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 24665 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157109.pdf [firstpage_image] =>[orig_patent_app_number] => 10041860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304332 [patent_doc_number] => 20040115738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Polypeptides having a triggering nk activity and biological applications' [patent_app_type] => new [patent_app_number] => 10/451843 [patent_app_country] => US [patent_app_date] => 2003-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8142 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115738.pdf [firstpage_image] =>[orig_patent_app_number] => 10451843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 443285 [patent_doc_number] => 07256269 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-14 [patent_title] => 'Immunogen adherence inhibitor and method of making and using same' [patent_app_type] => utility [patent_app_number] => 10/025567 [patent_app_country] => US [patent_app_date] => 2001-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9016 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/256/07256269.pdf [firstpage_image] =>[orig_patent_app_number] => 10025567 [rel_patent_id] =>[rel_patent_doc_number] =>)